breakout, page-16

Well done Brett, to everyone that's gotten in to date be it 2c or 29c.

Apart from having 3 plus years cash on hand, apart from having 6 genuine quality projects all firing, apart from gun management & low SOI.

I ask myself, how is a company like PTX with a market cap sub $200m attracting the board members it has? How are they attracting the 'Special Advisory Board' which is completely unpaid? How are they convincing the Peter MacCallum to dedicate 4 full-time clinicians to PTX portfolio? How are they getting Epworth & Professor Miles Prince to lead PTX-100 independently?

It's the equivalent of 6 Michelin star chefs walking into your family restaurant asking what smells so good on the stove?

Professor Phil Darcy- Head of Peter MacCallum CAR-T research, Professor Miles Prince- Head of Hematology at Epworth & world renowned, Professor Allen Ebens- Pioneer in CAR-T & prolific contributer to the science who took Juno to great heights, Professor Donald O'Rourke- World leading neurosurgeon at Penn University which is the birth place of CAR-T!

This company is sitting on some pretty bloody amazing bio tech & data already to date...How it's not already $500m-$1b escapes me? The IP is drawing these world leaders to us, they don't have time to sleep but they are jumping at PTX?

We are all seeing IMU race from $200m to almost $3b market cap...Well done to everyone across the pond.

I genuinely believe PTX is the next cab off the rank & I fully expect the company will breach $1b over the next 12-18 months as some pretty serious data starts to roll in and OmniCar hits arms for first time...In the mean time I expect another significant re-rate is imminent.